U.S. Industrials Stock News

NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Expedia Leans On AI Demand Data As Chatbot Booking Threat Eases

Expedia Group, NasdaqGS:EXPE, is integrating PredictHQ’s AI driven demand data into its Partner Central platform for lodging partners. The tools aim to give hotels and other properties more granular, real time and forward looking insight into traveler demand patterns. Separately, OpenAI is scaling back direct booking ambitions in ChatGPT, easing competitive concerns for online travel intermediaries. For investors watching Expedia Group, NasdaqGS:EXPE, the news comes with the shares trading...
NYSE:GDDY
NYSE:GDDYIT

Is It Time To Reconsider GoDaddy (GDDY) After Recent Share Price Weakness

If you are wondering whether GoDaddy's current share price lines up with its underlying worth, you are not alone. This article is built to help you think that through clearly. GoDaddy shares last closed at US$93.95, with a 7 day return of 7.8%, a 30 day return of 1.8% decline, a year to date return of 20.7% decline, a 1 year return of 46.4% decline, a 3 year return of 29.8% and a 5 year return of 29.7%. Recent moves in the share price have put more attention on how the market is currently...
NYSE:BANC
NYSE:BANCBanks

Assessing Banc of California (BANC) Valuation After Recent Share Price Weakness

What Banc of California’s Recent Share Performance Signals for Investors Banc of California (BANC) has drawn fresh attention after a recent pullback, with the stock down about 4% over the past day and 15% over the past month. This decline is prompting investors to reassess its current valuation. See our latest analysis for Banc of California. While the 30 day share price return of negative 15% and year to date share price return of negative 12.03% point to fading near term momentum, the 1...
NasdaqGS:DXPE
NasdaqGS:DXPETrade Distributors

How Earnings Upside And Insider Buying At DXP Enterprises (DXPE) Has Changed Its Investment Story

DXP Enterprises, Inc. has reported its fourth-quarter and full-year 2025 results, with full-year sales of US$2.02 billion and net income of US$88.68 million, alongside higher basic and diluted earnings per share from continuing operations than a year earlier. At the same time, recent insider share purchases by senior executives and macro pressures tied to Middle East tensions and energy prices are drawing attention to how company-specific confidence interacts with broader economic...
NYSE:DD
NYSE:DDChemicals

DuPont WAVE PRO Upgrade Supports Water Segment And Valuation Upside Potential

DuPont de Nemours (NYSE:DD) has expanded its WAVE PRO water treatment design tool to include reverse osmosis and nanofiltration capabilities. The upgrade broadens the platform for global water professionals who model and optimize complex treatment systems across multiple industries. The move highlights DuPont's push into digital solutions that support water and energy efficiency in sectors such as municipalities, desalination, and microelectronics. For investors watching NYSE:DD, the update...
NYSE:RYAN
NYSE:RYANInsurance

How Revenue Surge, Acquisitions and Empower Plan May Impact Ryan Specialty Holdings (RYAN) Investors

In 2025, Ryan Specialty Holdings Inc. reported a 21.3% increase in total revenue to over US$3.05 billion, completed five acquisitions expected to add more than US$125 million in annualized revenue, and launched the three-year Empower Program restructuring to streamline operations and target annual savings of US$80 million by 2029. This combination of strong top-line expansion, acquisition-driven scale in its Underwriting Management specialty, and a multi-year cost-efficiency plan highlights...
NasdaqGS:KTOS
NasdaqGS:KTOSAerospace & Defense

Is It Too Late To Consider Kratos Defense & Security Solutions (KTOS) After 7x Three Year Surge?

If you are wondering whether Kratos Defense & Security Solutions is priced for perfection or still offers value, it helps to step back and look at the numbers through a few different valuation lenses. The stock recently closed at US$87.00, with returns of 1.0% over the last week, a 4.7% decline over 30 days, 9.7% year to date, around 220% over one year and a very large gain over three years that is close to 7x, as well as 228.1% over five years, which can change how investors think about...
NYSE:PRKS
NYSE:PRKSHospitality

What United Parks & Resorts (PRKS)'s 10-K Delay and ERP Push Means For Shareholders

In late February 2026, United Parks & Resorts Inc. reported that fourth-quarter 2025 revenue slipped to US$373.55 million and net income to US$15.05 million, and on March 3 it disclosed a brief delay to its 2025 Form 10-K filing while it completes procedural reviews. At the same time, the company highlighted heavy share repurchases totaling hundreds of millions of US dollars, ongoing ERP implementation, and exploration of a SeaWorld Orlando adjacent development, underscoring a major...
NYSE:MSGE
NYSE:MSGEEntertainment

Is It Too Late To Consider Madison Square Garden Entertainment (MSGE) After Its 85% One-Year Surge

If you are wondering whether Madison Square Garden Entertainment is still good value after its recent run, this article will walk through what the current share price might be implying. The stock closed at US$58.84, with a 1 year return of 84.7%, an 8.3% gain year to date, a 1.6% decline over the last 30 days, and a 6.8% decline over the last week, which may signal shifting views on its potential and risk. Recent coverage has focused on Madison Square Garden Entertainment as a live...
NYSE:MOH
NYSE:MOHHealthcare

Is Molina Healthcare (MOH) Now an Opportunity After a 56% One Year Share Price Fall

If you are wondering whether Molina Healthcare's current share price lines up with its underlying value, you are not alone. That is exactly what this article will unpack. Molina Healthcare's share price closed at US$144.47, with returns of 6.2% decline over 7 days, 18.9% decline over 30 days, 19.0% decline year to date, 55.9% decline over 1 year, 44.7% decline over 3 years, and 37.9% decline over 5 years that may have changed how some investors view its risk and potential. Recent news flow...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

XDEMVY Growth And China Deal Reshape Tarsus Pharmaceuticals Investment Story

Tarsus Pharmaceuticals reports strong launch momentum for XDEMVY in Demodex blepharitis, supporting rapid revenue growth. The company signs an agreement to develop and commercialize XDEMVY in China, extending its reach into a major new market. Tarsus continues to advance its pipeline in ocular rosacea and Lyme disease prevention alongside XDEMVY commercialization. Tarsus Pharmaceuticals, listed as NasdaqGS:TARS, is gaining attention as XDEMVY becomes a meaningful revenue driver and helps...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Is It Too Late To Consider Phibro Animal Health (PAHC) After 1-Year Share Price Surge?

If you are wondering whether Phibro Animal Health's current share price reflects its real worth, you are not alone, many investors are asking the same question. The stock last closed at US$47.92, with returns of 16.9% over 30 days, 28.5% year to date and 105.4% over 1 year, while the past 3 and 5 years show returns of 237.6% and 121.2% respectively, along with a 12.2% decline over the last 7 days. Recent coverage around animal health, biosecurity and livestock productivity has kept attention...
NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

Is Kyivstar Group (KYIV) Pricing Reflect Its Mixed Performance And Conflicting Valuation Signals

If you are wondering whether Kyivstar Group's current share price reflects its underlying worth, you are not alone. This article will walk you through what the numbers are actually saying about value. The stock recently closed at US$11.88, with returns of 0.5% over the last week, 0.3% over the last month, a 10.5% decline year to date and 2.9% over the past year. This gives you a mixed picture of how sentiment has shifted. Recent coverage around Kyivstar Group has focused on its position in...
NasdaqGS:AKTS
NasdaqGS:AKTSBiotechs

Aktis Oncology Fast Track Win Highlights AKY-1189 Potential And Key Risks

Aktis Oncology (NasdaqGS:AKTS) received FDA Fast Track designation for AKY-1189 in advanced urothelial cancer. The designation aims to support faster clinical development and regulatory review for this radiopharmaceutical candidate. The company also provided updates on the ongoing NECTINIUM-2 Phase 1b trial of AKY-1189. Aktis Oncology focuses on radiopharmaceutical therapies, targeting cancers that can be difficult to treat with existing options. For investors watching NasdaqGS:AKTS, the...
NYSE:APD
NYSE:APDChemicals

A Look At Air Products And Chemicals (APD) Valuation As Short Interest Eases And Yara Projects Advance

Air Products and Chemicals (APD) is back in focus after short interest as a share of float declined, and management reaffirmed growth guidance while progressing large projects with Yara International in the U.S. and Saudi Arabia. See our latest analysis for Air Products and Chemicals. At a share price of $272.18, Air Products and Chemicals has had an 8.67% year to date share price return. The 1 year total shareholder return of an 11.69% decline contrasts with a 3 year total shareholder return...
NYSE:IHS
NYSE:IHSTelecom

IHS Holding Buyout By MTN Turns Tower Growth Story Into Cash Exit

IHS Holding (NYSE:IHS) has agreed to be acquired by MTN Group in an all cash transaction. The merger agreement has received full approval from the IHS Holding Board. The deal offers shareholders immediate liquidity with a premium to the recent trading price. The announcement comes during a period of challenging market and geopolitical conditions for tower operators. IHS Holding runs telecom tower infrastructure across multiple emerging markets, giving mobile operators shared access to...
NYSE:TDS
NYSE:TDSWireless Telecom

Assessing Telephone And Data Systems (TDS) Valuation After Wireless Sale And New VR Advisory Position

Telephone and Data Systems (TDS) is back in focus after VR Advisory Services opened a sizable new position, shortly after the company sold its wireless operations in 2025 and improved its balance sheet. See our latest analysis for Telephone and Data Systems. The share price, which last closed at US$44.91, has had a mixed few weeks, with a 30 day share price return of a 3.75% decline but a stronger 90 day share price return of 13.98%. Meanwhile, the 1 year total shareholder return of 27.43%...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Cisco Deepens Role In Secure AI And 6G As Revenue Question Looms

Cisco Systems (NasdaqGS:CSCO) launched Australia's first Cisco Secure AI Factory with SharonAI and NVIDIA, focused on secure, high-performance AI infrastructure. The Secure AI Factory aims to support sovereign AI development in Australia by keeping sensitive data local while providing access to advanced compute and networking. Cisco is expanding its involvement in global 6G development and working more closely with major AI focused hyperscalers. Together, these moves highlight Cisco's push...
NasdaqGS:KHC
NasdaqGS:KHCFood

Is Kraft Heinz (KHC) Quietly Offering Value After Multi Year Share Price Weakness

If you are wondering whether Kraft Heinz shares are quietly offering value or still carrying old baggage, you are in the right place to unpack what the current price really implies. The stock closed at US$24.54 recently, with returns of 0.2% over 30 days and 0.6% year to date, while the 1 year return of an 18.9% decline and 3 year return of a 24.4% decline may have tested long term holders' patience. Recent news around Kraft Heinz has largely focused on how the company is reshaping its...
NYSE:CWT
NYSE:CWTWater Utilities

Assessing California Water Service Group (CWT) Valuation After Recent Steady Trading And Modest Return Profile

California Water Service Group (CWT) is under the spotlight after recent trading left the stock at $45.59, prompting investors to reassess how its current price lines up with its fundamentals and long term return profile. See our latest analysis for California Water Service Group. Recent trading has been relatively steady, with a 7 day share price return of 1.13% and a year to date share price return of 6.15%, while the 1 year total shareholder return is a 2.25% decline, suggesting momentum...
NYSE:TRV
NYSE:TRVInsurance

Is Travelers Companies (TRV) Still Attractive After Strong Multi Year Share Price Gains

If you are wondering whether Travelers Companies at around US$306 per share still offers reasonable value, you are not alone. This article is designed to help you weigh what the current price might be implying. The stock has been relatively steady in the very short term with a 0.8% decline over the last 7 days, while the 30 day, year to date and 1 year returns of 3.8%, 7.4% and 20.8% give a fuller picture of how the market has been pricing it recently. Alongside these moves, investors have...
NYSE:D
NYSE:DIntegrated Utilities

What Dominion Energy (D)'s Data Center Spending Surge and 2026 Outlook Means For Shareholders

In February 2026, Dominion Energy reported past fourth-quarter 2025 sales of US$4,093 million and net income of US$567 million, alongside full-year 2025 sales of US$16.51 billion and net income of US$3.00 billion, and issued 2026 operating earnings guidance of US$3.45–US$3.69 per share. An important angle for investors is Dominion’s decision to significantly lift its 2026–2030 capital spending to US$64.70 billion to meet surging, data center-driven electricity demand from major technology...
NasdaqGS:NXST
NasdaqGS:NXSTMedia

A Look At Nexstar Media Group (NXST) Valuation After Recent Share Price Strength

Nexstar Media Group (NXST) shares have quietly moved higher over the past 3 months, with the stock up about 31% and roughly 16% over the past month, prompting closer attention from investors. See our latest analysis for Nexstar Media Group. Those recent gains sit within a stronger backdrop, with an 18.6% year to date share price return and a 44.6% total shareholder return over the past year, hinting at improving sentiment despite some short term pullbacks. If Nexstar’s move has you thinking...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Reassessing Atlassian (TEAM) After Sharp Share Price Pullback and Cash Flow Outlook

If you have been wondering whether Atlassian is starting to look attractively priced or still expensive, this article walks through what the current share price might actually imply. At a last close of US$83.62, the stock has had a mixed run, with an 11.3% gain over the past week but declines of 20.4% over 30 days, 46.0% year to date, and 65.0% over the past year, as well as 46.3% over 3 years and 63.5% over 5 years. Recent coverage around Atlassian has focused on how collaboration and...